Knowing stock market today at a glance

Rocket Pharmaceuticals (RCKT) Shares Soar 12.73% After 52-Week Low

Mover TrackerWednesday, Apr 9, 2025 8:06 pm ET

1min read

Rocket Pharmaceuticals (RCKT) shares surged by 12.73% today, marking a significant rebound from its record low intraday decline of 5.01%.

Rocket Pharmaceuticals' stock price has been under pressure recently, hitting a new 52-week low of $4.60. This decline can be attributed to several factors, including the sale of 7,489 shares by the company's Chief Financial Officer, Aaron Ondrey. Such insider selling often raises concerns among investors about the company's future prospects.

Adding to the pressure, Needham & Company LLC recently lowered their price target for rocket pharmaceuticals from $52.00 to $42.00. This reduction in the price target reflects a more cautious outlook on the company's performance, which can further dampen investor sentiment. However, today's surge suggests that some investors may be seeing value in the stock at its current levels, despite the recent setbacks.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.